Overview

Mast-Cell Stabilizing Effects of Olopatadine

Status:
Completed
Trial end date:
1969-12-31
Target enrollment:
Participant gender:
Summary
To assess the effects of olopatadine of the release of mast cell histamine
Phase:
Phase 4
Details
Lead Sponsor:
Alcon Research
Treatments:
Olopatadine Hydrochloride